CORC  > 山东大学
Lobaplatin promotes 125I-induced apoptosis and inhibition of proliferation in hepatocellular carcinoma by upregulating PERK-eIF2α-ATF4-CHOP pathway
Li D.; Wang W.-J.; Wang Y.-Z.; Wang Y.-B.; Li Y.-L.
刊名Cell Death and Disease
2019
卷号10期号:10
DOI10.1038/s41419-019-1918-1
URL标识查看原文
公开日期[db:dc_date_available]
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/4554028
专题山东大学
作者单位1.Department of Interventional Medicine, The Second Hospital of Shandong University, Jinan, China
2.Department of Interventional Med
推荐引用方式
GB/T 7714
Li D.,Wang W.-J.,Wang Y.-Z.,et al. Lobaplatin promotes 125I-induced apoptosis and inhibition of proliferation in hepatocellular carcinoma by upregulating PERK-eIF2α-ATF4-CHOP pathway[J]. Cell Death and Disease,2019,10(10).
APA Li D.,Wang W.-J.,Wang Y.-Z.,Wang Y.-B.,&Li Y.-L..(2019).Lobaplatin promotes 125I-induced apoptosis and inhibition of proliferation in hepatocellular carcinoma by upregulating PERK-eIF2α-ATF4-CHOP pathway.Cell Death and Disease,10(10).
MLA Li D.,et al."Lobaplatin promotes 125I-induced apoptosis and inhibition of proliferation in hepatocellular carcinoma by upregulating PERK-eIF2α-ATF4-CHOP pathway".Cell Death and Disease 10.10(2019).
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace